Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.4, 2008-04, pp. : 507-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on the use of ophthalmic ketorolac tromethamine 0.4%

By Perry Henry D Donnenfeld Eric D

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 99-107

Informa Healthcare

Access to resources Recommend Favorite

Formulation and Optimization of a Sustained-Release Tablet of Ketorolac Tromethamine

By Vatsaraj Neha Zia Hossein Needham Thomas

Drug Delivery, Vol. 9, Iss. 3, 2002-07 ,pp. : 153-159

Informa Healthcare

Access to resources Recommend Favorite

Influence of Ultrasound on the Percutaneous Absorption of Ketorolac Tromethamine In Vitro Across Rat Skin

By Tiwari Sandip Pai Raveendra Udupa N.

Drug Delivery, Vol. 11, Iss. 1, 2004-01 ,pp. : 47-51

Informa Healthcare

Access to resources Recommend Favorite

Formulation, Characterization, and Evaluation of Ketorolac Tromethamine-Loaded Biodegradable Microspheres

By Sinha Vivek Trehan Aman

Drug Delivery, Vol. 12, Iss. 3, 2005-05 ,pp. : 133-139

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Topical Gels Containing Ketorolac Tromethamine on Inflammation and Hyperalgesia in Rats

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 10, Iss. 5, 2011-10 ,pp. : 323-326

Bentham Science Publishers

Access to resources Recommend Favorite